M
Michiel L. Bots
H-index:112
Citation Count:5.8万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral Angioplasty
CLEAR-PATH出血安全性更新:外周血管成形术后30天和12个月的抗血小板治疗
EJVES Vascular Forum
IF1.8
Health status in different subgroups of people receiving hemodiafiltration versus hemodialysis for renal replacement therapy: a subgroup analysis of the CONVINCE randomized controlled trial
接受血液透析滤过与血液透析进行肾脏替代治疗的不同人群亚组健康状态:CONVINCE随机对照试验的亚组分析
Haemodiafiltration versus haemodialysis for kidney failure – Authors' reply
血液透析滤过与血液透析治疗肾衰竭——作者回复
The Lancet
IF0
Polypharmacy in Patients with CKD A Systematic Review and Meta-Analysis
CKD患者的多重用药: 系统评价和Meta分析
KIDNEY360
IF3
Association of mild kidney dysfunction with diastolic dysfunction and heart failure with preserved ejection fraction
轻度肾功能障碍与舒张功能障碍和射血分数保留的心力衰竭的关系
ESC HEART FAILURE
IF3.7

